GL1X · GenesisL1 explorer

Research workbench

Crystal structure of human KRAS G12A mutant in complex with GTP

Analyse Crystal structure of human KRAS G12A mutant in complex with GTP in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5VPI
Type
protein
Length
318 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
GTPase KRAS
UniProt
P01116
Ligands
GTP, MG
Pockets
4 · best druggability 0.53

Structure

x-ray diffraction · 1 distinct chain · 36% helix, 26% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BGTPase KRASprotein15936% helix, 26% strandP01116

Ligands and binding sites

  • GTP · Guanosine-5'-triphosphate · ligand · 2 copies · chains A, B
  • MG · Magnesium ion · metal · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11850.530.7929GTP, MG
21670.510.7929GTP, MG
3810.440.8029empty
4720.300.7422empty

Interfaces

1 interface between chains.

  • A–B · 1006 Ų buried · 21 hydrogen bonds · protein-protein

Compared structures

  • 5VPI · Crystal structure of human KRAS G12A mutant in complex with GTP · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.